KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q1 2020 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI)
Q1 2020 Earnings Conference Call
May 5, 2020, 08:30 AM ET
Company Participants
Ian Karp - VP, Investor and Public Relations
Michael Kauffman - CEO
John Demaree - Chief Commercial Officer
Mike Mason - CFO
Perry Monaco - SVP, Sales
Chris Primiano - Chief Business Officer and General Counsel
Sharon Shacham - President and Chief Scientific Officer
Conference Call Participants
Maury Raycroft - Jefferies
Brian Abrahams - RBC Capital Markets
Peter Lawson - Barclays
Jonathan Chang - SVB Leerink Partners LLC
Mike Ulz - Baird
Arlinda Lee - Canaccord
Ed White